EMR Form 4: Officer tax-withholding of 1,981 shares disclosed

Rhea-AI Filing Summary

Emerson Electric (EMR) insider filing: Executive Vice President, CFO & CAO Michael J. Baughman reported a routine tax-withholding transaction on 11/04/2025. The filing shows 1,981 shares of common stock were withheld to cover required minimum taxes upon vesting of a previously reported stock grant under a shareholder‑approved plan exempt pursuant to Rule 16b‑3, at a fair market value of $138.315 per share.

Following the transaction, Baughman beneficially owns 132,262 shares directly and 563.357 shares indirectly through a 401(k) excess plan. This Form 4 reflects administrative share withholding tied to equity vesting rather than an open‑market sale.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Baughman Michael J

Role Exec VP, CFO & CAO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,981	$138.315	$274K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 132,262 shares (Direct); Common Stock — 563.357 shares (Indirect, 401(k) excess plan)

Footnotes (1)

1. Shares withheld for required minimum taxes upon vesting of previously reported stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3. Fair market value on date of withholding described in Note 1.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baughman Michael J

(Last) (First) (Middle)

C/O EMERSON ELECTRIC CO.

8027 FORSYTH BLVD.

(Street)

ST. LOUIS MO 63105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EMERSON ELECTRIC CO [ EMR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec VP, CFO & CAO

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2025		F(1)		1,981(1)	D	$138.315(2)	132,262	D
Common Stock								563.357	I	401(k) excess plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld for required minimum taxes upon vesting of previously reported stock grant under shareholder approved benefit plan exempt pursuant to Rule 16b-3.

2. Fair market value on date of withholding described in Note 1.

Remarks:

	/s/ John A. Sperino, Attorney-in-Fact for Michael J. Baughman	11/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did EMR report in this Form 4?

An officer reported 1,981 shares of common stock withheld to cover taxes upon vesting of a stock grant on 11/04/2025.

What price was used for the tax-withholding shares?

The fair market value was $138.315 per share on the withholding date.

Who is the reporting person in EMR’s Form 4?

Michael J. Baughman, Exec VP, CFO & CAO of Emerson Electric.

How many EMR shares does the officer own after the transaction?

Beneficial ownership is 132,262 shares directly and 563.357 shares indirectly via a 401(k) excess plan.

What does transaction code F indicate in this context?

Code F indicates shares withheld for taxes upon vesting of an equity award under a shareholder‑approved plan exempt under Rule 16b‑3.

Is this an open-market sale of EMR stock?

No. It reflects administrative tax withholding tied to equity vesting, not an open‑market sale.